Recent Posts

• Handa Pharmaceuticals, Inc. Announces Launch of Proprietary ONCORE® Oncology Drug Delivery Technology Platform
• Handa Pharmaceuticals Announces TruPharma’s U.S. Launch Of Its FDA-Approved ANDA for Lamotrigine Extended Release Tablets
• Handa Pharmaceuticals, Inc. Announces FDA Approval for Generic Version of AstraZeneca’s SEROQUEL XR® Extended Release Tablets
• Taiwan Authorities Approve Public Issuance of Handa Stock
• Handa Pharmaceuticals Announces Endo Begins Shipping Generic Version of AstraZeneca’s SEROQUEL XR®